Research ArticleBasic Science Investigations
Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer
Amey Bandekar, Charles Zhu, Rohit Jindal, Frank Bruchertseifer, Alfred Morgenstern and Stavroula Sofou
Journal of Nuclear Medicine January 2014, 55 (1) 107-114; DOI: https://doi.org/10.2967/jnumed.113.125476
Amey Bandekar
1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and
Charles Zhu
1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and
Rohit Jindal
1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and
Frank Bruchertseifer
2Alpha-Immunotherapy, European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany
Alfred Morgenstern
2Alpha-Immunotherapy, European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany
Stavroula Sofou
1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 1
January 1, 2014
Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer
Amey Bandekar, Charles Zhu, Rohit Jindal, Frank Bruchertseifer, Alfred Morgenstern, Stavroula Sofou
Journal of Nuclear Medicine Jan 2014, 55 (1) 107-114; DOI: 10.2967/jnumed.113.125476
Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer
Amey Bandekar, Charles Zhu, Rohit Jindal, Frank Bruchertseifer, Alfred Morgenstern, Stavroula Sofou
Journal of Nuclear Medicine Jan 2014, 55 (1) 107-114; DOI: 10.2967/jnumed.113.125476